Skip to main content
Fig. 3 | Trials

Fig. 3

From: Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)

Fig. 3

Schedule of enrolment, interventions, and assessments. BDI, baseline dyspnoea index; CATest, COPD (Chronic Obstructive Pulmonary Disease) Assessment Test; EQ-5D-5L, EuroQOL five-dimension questionnaire; hs-cTnI high-sensitivity cardiac troponin I; NTproBNP N-terminal pro-Brain Natriuretic PeptideN; OCS oral corticosteroids; TDI transition dyspnoea index

Back to article page

Trials

ISSN: 1745-6215